| 000 | 00743 a2200229 4500 | ||
|---|---|---|---|
| 005 | 20250512170337.0 | ||
| 264 | 0 | _c19710706 | |
| 008 | 197107s 0 0 eng d | ||
| 022 | _a0014-9446 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAzarnoff, D L | |
| 245 | 0 | 0 |
_aPharmacology of hypolipidemic drugs. Introduction. _h[electronic resource] |
| 260 |
_bFederation proceedings _c |
||
| 300 |
_a827-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCholesterol _xbiosynthesis |
| 650 | 0 | 4 | _aClofibrate |
| 650 | 0 | 4 |
_aHypolipidemic Agents _xpharmacology |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 773 | 0 |
_tFederation proceedings _gvol. 30 _gno. 3 _gp. 827-8 |
|
| 999 |
_c5576218 _d5576218 |
||